1. Home
  2. SGP vs CRON Comparison

SGP vs CRON Comparison

Compare SGP & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$21.47

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$2.67

Market Cap

985.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGP
CRON
Founded
2019
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
932.9M
985.8M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SGP
CRON
Price
$21.47
$2.67
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$45.00
N/A
AVG Volume (30 Days)
50.8K
2.2M
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
N/A
$146,587,000.00
Revenue This Year
N/A
$26.34
Revenue Next Year
N/A
$15.53
P/E Ratio
N/A
$65.38
Revenue Growth
N/A
24.63
52 Week Low
$20.15
$1.84
52 Week High
$30.56
$3.43

Technical Indicators

Market Signals
Indicator
SGP
CRON
Relative Strength Index (RSI) 37.76 50.93
Support Level $20.95 $2.47
Resistance Level $26.29 $2.72
Average True Range (ATR) 1.42 0.10
MACD -0.27 -0.01
Stochastic Oscillator 6.94 27.62

Price Performance

Historical Comparison
SGP
CRON

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

About CRON Cronos Group Inc.

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: